Azenta grants William E. Martin III 17,576 stock units
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Azenta, Inc. (AZTA) President Multiomics William E. Martin III received a grant of 17,576 restricted stock units on November 12, 2026. The units are payable solely in common shares, and no amount was paid upon grant. His reported direct holdings following the grant were 50,638 shares. The award vests 33-1/3% per year beginning November 15, 2027, subject to the award agreement.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common F1 | 17,576 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2027, subject to the terms of the award agreement.
Key Figures
Key Terms
restricted stock units financial
time-based vesting financial
Equity Incentive Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many restricted stock units did AZTA's President Multiomics receive, and when do they vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.